Inhaled steroid delivery from small-volume holding chambers depends on age, holding chamber, and interface in

Jean-Christophe Dubus1, Jacob Anhøj

  • 1Unité de Médecine Infantile, CHU Timone-Enfants, Marseille, France. jean-christophe.dubus@ap-hm.fr

Insights

Inhaled steroid delivery via holding chambers significantly increases with patient age. Device choice and inhalation interface (mask vs. mouthpiece) also impact drug delivery for asthma patients.

Area of Science:

  • Respiratory Medicine
  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Pressurized metered-dose inhalers (pMDIs) with holding chambers are common for delivering inhaled corticosteroids (ICS) to children.
  • Optimal drug delivery is crucial for managing pediatric asthma effectively.
  • Factors influencing ICS delivery, such as patient age and device interface, require further investigation.

Purpose of the Study:

  • To investigate the relationship between patient age, holding chamber type, and inhalation interface on the delivery of inhaled steroids from pMDIs.
  • To quantify the amount of inhaled steroid reaching the filter (proxy for lung deposition) across different age groups and device configurations.

Main Methods:

  • An open, randomized, cross-over filter study was conducted with 4 groups of children (infants to adolescents) with varying asthma severity.
  • Budesonide (Nebuchamber) and fluticasone propionate (Babyhaler) were administered via pMDIs with their respective holding chambers.
  • Drug delivery was measured using filters, analyzed by high-performance liquid chromatography, and modeled using mixed-effects linear regression.

Main Results:

  • Inhaled steroid delivery significantly increased with age for both holding chambers, from 3-7% in infants to 40-41% in adolescents.
  • Nebuchamber showed higher drug delivery than Babyhaler (p=0.002).
  • Using a mouthpiece resulted in lower filter doses compared to a facemask for both devices (p<0.0001).

Conclusions:

  • Inhaled steroid delivery from pMDIs with holding chambers is significantly influenced by patient age, holding chamber type, and inhalation interface.
  • These findings highlight the need for age-appropriate device selection and interface use in pediatric asthma management.
  • Further clinical studies are warranted to compare lung deposition and clinical outcomes between mouthpiece and facemask inhalation from holding chambers.

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...